Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease

Faecal microbiota transplant (FMT) has now been established into clinical guidelines for the treatment of recurrent and refractory Clostridioides difficile infection (CDI). Its therapeutic application in inflammatory bowel disease (IBD) is currently at an early stage. To date, there have been four r...

Descripción completa

Detalles Bibliográficos
Autores principales: Yalchin, Mehmet, Segal, Jonathan P., Mullish, Benjamin H., Quraishi, Mohammed Nabil, Iqbal, Tariq H., Marchesi, Julian R., Hart, Ailsa L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Prospects and Challenges into the Role of Gut Microbiome in Health and Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878609/
https://www.ncbi.nlm.nih.gov/pubmed/31803254
http://dx.doi.org/10.1177/1756284819891038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878609/
https://www.ncbi.nlm.nih.gov/pubmed/31803254
http://dx.doi.org/10.1177/1756284819891038

Ejemplares similares